← Leaderboards
Mark Alan Sussman
Children'S Hospital Med Ctr (Cincinnati)
$29,038,987
Attributed
$30,383,855
Total exposure
25
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.2M · FY2005–21$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$61,953,021 · 28
By mechanism
P01$26,136,753 · 9
R01$16,277,052 · 9
U54$13,158,257 · 2
R37$3,763,091 · 1
R21$1,233,375 · 3
RC1$1,000,000 · 1
Top collaborators
- Elva M Arredondo15 shared
- Maria Elena Martinez11 shared
- Sheila E. Crowe10 shared
- Natalie Allen Gude5 shared
- Joseph C Wu2 shared
- James D Murphy1 shared
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacMyocardialHeartMediatingMyocardiumRepairedBaseMolecularHeart FailureSignal TransductionInjuryCardiac MyocytesStem CellsInnovationNatural RegenerationIn VivoCellsResponseHeart DiseasesProgramsRegenerativeStructureAgingRegulation
Grant awards (132)
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership$749,999
U54 · FY2021 · CA
Regulation of Signal Transduction to Treat Heart Failure$376,250
R01 · FY2021 · HL · contact PI
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership$618,179
U54 · FY2020 · CA
Resolving myocardial regeneration by tracking commitment of c-Kit+ cells$453,139
R01 · FY2020 · HL · contact PI
Regulation of Signal Transduction to Treat Heart Failure$376,250
R01 · FY2020 · HL · contact PI
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership$1,263,028
U54 · FY2019 · CA
Resolving myocardial regeneration by tracking commitment of c-Kit+ cells$453,139
R01 · FY2019 · HL · contact PI
Regulation of Signal Transduction to Treat Heart Failure$376,250
R01 · FY2019 · HL · contact PI
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership$1,304,869
U54 · FY2018 · CA
Regulation of Signal Transduction to Treat Heart Failure$376,250
R01 · FY2018 · HL · contact PI
Resolving myocardial regeneration by tracking commitment of c-Kit+ cells$376,250
R01 · FY2018 · HL · contact PI
Resolving myocardial regeneration by tracking commitment of c-Kit+ cells$31,478
R01 · FY2018 · HL · contact PI
Restoring Mycocardial Healing$1,742,983
P01 · FY2017 · HL · contact PI
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership$1,258,708
U54 · FY2017 · CA
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership$1,192,222
U54 · FY2017 · CA
Resolving myocardial regeneration by tracking commitment of c-Kit+ cells$375,730
R01 · FY2017 · HL · contact PI
Beta-adrenergic signaling: double edged sword of myocardial repair$373,750
R01 · FY2017 · HL · contact PI
Stem Cell Signaling in the Pathologically Challenged Myocardium$373,750
R37 · FY2017 · HL · contact PI
Enhanced Myocardial Repair with CardioClusters and CardioChimeras$373,750
R01 · FY2017 · HL · contact PI
Next Generation Regenerative Therapy with Pim-1 Enhanced Cardiac Progenitor Cells$265,893
R41 · FY2017 · HL · contact PI
Physiology and Surgery$232,803
P01 · FY2017 · HL · contact PI
Restoration of Myocardial Healing by Extracellular Matrix Remodeling$182,062
P01 · FY2017 · HL · contact PI
Administrative Core A$102,389
P01 · FY2017 · HL · contact PI
Restoring Mycocardial Healing$1,742,983
P01 · FY2016 · HL · contact PI
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership$1,293,750
U54 · FY2016 · CA
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership$1,082,983
U54 · FY2016 · CA
Stem Cell Signaling in the Pathologically Challenged Myocardium$373,750
R37 · FY2016 · HL · contact PI
Beta-adrenergic signaling: double edged sword of myocardial repair$373,750
R01 · FY2016 · HL · contact PI
Enhanced Myocardial Repair with CardioClusters and CardioChimeras$373,750
R01 · FY2016 · HL · contact PI
Cardioprotection by optimizing mTOR activity$373,750
R01 · FY2016 · HL · contact PI
Physiology and Surgery$232,803
P01 · FY2016 · HL · contact PI
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership$199,986
U54 · FY2016 · CA
Restoration of Myocardial Healing by Extracellular Matrix Remodeling$182,062
P01 · FY2016 · HL · contact PI
Administrative Core A$102,389
P01 · FY2016 · HL · contact PI
Restoring Mycocardial Healing$1,770,949
P01 · FY2015 · HL · contact PI
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership$1,379,196
U54 · FY2015 · CA
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership$1,266,713
U54 · FY2015 · CA
Antagonism of myocardial aging and senescence with Pim-1 kinase$368,143
R01 · FY2015 · HL · contact PI
Enhanced Myocardial Repair with CardioClusters and CardioChimeras$368,143
R01 · FY2015 · HL · contact PI
Regulation of Signal Transduction to Treat Heart Failure$368,143
R01 · FY2015 · HL · contact PI
Cardioprotection by optimizing mTOR activity$368,143
R01 · FY2015 · HL · contact PI
Beta-adrenergic signaling: double edged sword of myocardial repair$368,143
R01 · FY2015 · HL · contact PI
Stem Cell Signaling in the Pathologically Challenged Myocardium$368,143
R37 · FY2015 · HL · contact PI
Physiology and Surgery$236,226
P01 · FY2015 · HL · contact PI
Restoration of Myocardial Healing by Extracellular Matrix Remodeling$189,481
P01 · FY2015 · HL · contact PI
Administrative Core A$105,814
P01 · FY2015 · HL · contact PI
Restoring Mycocardial Healing$31,376
P01 · FY2015 · HL · contact PI
Restoring Mycocardial Healing$1,708,124
P01 · FY2014 · HL · contact PI
Enhanced Myocardial Repair with CardioClusters and CardioChimeras$373,750
R01 · FY2014 · HL · contact PI
Antagonism of myocardial aging and senescence with Pim-1 kinase$366,275
R01 · FY2014 · HL · contact PI
Stem Cell Signaling in the Pathologically Challenged Myocardium$366,275
R37 · FY2014 · HL · contact PI
Regulation of Signal Transduction to Treat Heart Failure$366,275
R01 · FY2014 · HL · contact PI
Beta-adrenergic signaling: double edged sword of myocardial repair$366,275
R01 · FY2014 · HL · contact PI
Cardioprotection by optimizing mTOR activity$366,275
R01 · FY2014 · HL · contact PI
Comprehensive SDSU/UCSD Cancer Center Partnership 1 of 2$220,574
U54 · FY2014 · CA
Physiology and Surgery$220,401
P01 · FY2014 · HL · contact PI
Restoration of Myocardial Healing by Extracellular Matrix Remodeling$170,677
P01 · FY2014 · HL · contact PI
Administrative Core A$92,596
P01 · FY2014 · HL · contact PI
Restoring Mycocardial Healing$1,676,223
P01 · FY2013 · HL · contact PI
Beta-adrenergic signaling: double edged sword of myocardial repair$373,750
R01 · FY2013 · HL · contact PI
Cardioprotection by optimizing mTOR activity$373,750
R01 · FY2013 · HL · contact PI
Regulation of Signal Transduction to Treat Heart Failure$355,810
R01 · FY2013 · HL · contact PI
Stem Cell Signaling in the Pathologically Challenged Myocardium$355,810
R37 · FY2013 · HL · contact PI
Antagonism of myocardial aging and senescence with Pim-1 kinase$355,810
R01 · FY2013 · HL · contact PI
Molecular Engineering of Damaged Myocardium To Enhance Regeneration And Repair$293,168
R01 · FY2013 · HL · contact PI
Physiology and Surgery$225,245
P01 · FY2013 · HL · contact PI
Restoration of Myocardial Healing by Extracellular Matrix Remodeling$159,183
P01 · FY2013 · HL · contact PI
Administrative Core A$89,953
P01 · FY2013 · HL · contact PI
Comprehensive SDSU/UCSD Cancer Center Partnership 1 of 2$1
U54 · FY2013 · CA
Comprehensive SDSU/UCSD Cancer Center Partnership 1 of 2$1,158,050
U54 · FY2012 · CA
Regulation of Signal Transduction to Treat Heart Failure$373,750
R01 · FY2012 · HL · contact PI
Molecular Engineering of Damaged Myocardium To Enhance Regeneration And Repair$373,750
R01 · FY2012 · HL · contact PI
Antagonism of myocardial aging and senescence with Pim-1 kinase$373,750
R01 · FY2012 · HL · contact PI
Stem Cell Signaling in the Pathologically Challenged Myocardium$370,013
R37 · FY2012 · HL · contact PI
Comprehensive SDSU/UCSD Cancer Center Partnership 1 of 2$169,999
U54 · FY2012 · CA
Antagonism of myocardial aging and senescence with Pim-1 kinase$373,750
R01 · FY2011 · HL · contact PI
Stem Cell Signaling in the Pathologically Challenged Myocardium$373,750
R37 · FY2011 · HL · contact PI
Inducible Notch improves progenitor cell repair of damaged heart$224,250
R21 · FY2011 · HL · contact PI
Control of Cardiac Growth by Ca2+Dependent Phosphorylation of Histones$224,250
R21 · FY2011 · HL · contact PI
Nucleolar disruption in response to cardiomyopathic stress and injury$186,875
R21 · FY2011 · HL · contact PI
Symposium: AHA Council on Basic Cardiovascular Sciences$15,000
R13 · FY2011 · HL · contact PI
Protecting Myocardium by Enhancing Mitochodrial Integrity$2,045,696
P01 · FY2010 · HL · contact PI
Engineering Cardiac Progenitor Cells to Enhance Myrocardial Regengeration$500,000
RC1 · FY2010 · HL · contact PI
Stem Cell Signaling in the Pathologically Challenged Myocardium$403,925
R37 · FY2010 · HL · contact PI
Preservation of mitochondrial integrity by Pim-1$349,595
P01 · FY2010 · HL · contact PI
Nucleolar disruption in response to cardiomyopathic stress and injury$224,250
R21 · FY2010 · HL · contact PI
Inducible Notch improves progenitor cell repair of damaged heart$186,875
R21 · FY2010 · HL · contact PI
Control of Cardiac Growth by Ca2+Dependent Phosphorylation of Histones$186,875
R21 · FY2010 · HL · contact PI
Protecting Myocardium by Enhancing Mitochodrial Integrity$45,263
P01 · FY2010 · HL · contact PI
Stem Cell Signaling in the Pathologically Challenged Myocardium$30,175
R37 · FY2010 · HL · contact PI
Protecting Myocardium by Enhancing Mitochodrial Integrity$1,976,109
P01 · FY2009 · HL · contact PI
Engineering Cardiac Progenitor Cells to Enhance Myrocardial Regengeration$500,000
RC1 · FY2009 · HL · contact PI
Stem Cell Signaling in the Pathologically Challenged Myocardium$373,750
R37 · FY2009 · HL · contact PI
Akt activation to treat heart failure$354,382
R01 · FY2009 · HL · contact PI
Preservation of mitochondrial integrity by Pim-1$327,307
P01 · FY2009 · HL · contact PI
Protecting Myocardium by Enhancing Mitochodrial Integrity$1,884,388
P01 · FY2008 · HL · contact PI
Stem Cell Signaling in the Pathologically Challenged Myocardium$373,750
R37 · FY2008 · HL · contact PI
POTENTIATION OF CARDIAC STEM CELL TO RETARD AGING$361,195
P01 · FY2008 · AG · contact PI
Akt activation to treat heart failure$354,382
R01 · FY2008 · HL · contact PI
Preservation of mitochondrial integrity by Pim-1$310,020
P01 · FY2008 · HL · contact PI
CORE--VIRAL VECTOR$227,813
P01 · FY2008 · AG · contact PI
Protecting Myocardium by Enhancing Mitochodrial Integrity$1,871,021
P01 · FY2007 · HL · contact PI
Preservation of mitochondrial integrity by Pim-1$410,091
P01 · FY2007 · HL · contact PI
Akt activation to treat heart failure$354,382
R01 · FY2007 · HL · contact PI
POTENTIATION OF CARDIAC STEM CELL TO RETARD AGING$334,083
P01 · FY2007 · AG · contact PI
CORE--VIRAL VECTOR$151,338
P01 · FY2007 · AG · contact PI
Protecting Myocardium by Enhancing Mitochodrial Integrity$1,915,794
P01 · FY2006 · HL · contact PI
Akt activation to treat heart failure$364,967
R01 · FY2006 · HL · contact PI
Core--Adenovirus$329,030
P01 · FY2006 · HL · contact PI
POTENTIATION OF CARDIAC STEM CELL TO RETARD AGING$323,123
P01 · FY2006 · AG · contact PI
Preservation of mitochondrial integrity by Pim-1$312,961
P01 · FY2006 · HL · contact PI
CORE--VIRAL VECTOR$134,097
P01 · FY2006 · AG · contact PI
Administrative Core$111,551
P01 · FY2006 · HL · contact PI
Akt activation to treat heart failure$375,000
R01 · FY2005 · HL
Core--Adenovirus$322,833
P01 · FY2005 · HL
POTENTIATION OF CARDIAC STEM CELL TO RETARD AGING$314,769
P01 · FY2005 · AG
CORE--VIRAL VECTOR$130,191
P01 · FY2005 · AG
POTENTIATION OF CARDIAC STEM CELL TO RETARD AGING$305,449
P01 · FY2004 · AG
Akt activation as treatment for dilated cardiomyopathy$302,000
R01 · FY2004 · HL
CYTOSKELETAL ADHESION IN CARDIAC REMODELING$302,000
R01 · FY2004 · HL
CORE--VIRAL VECTOR$140,339
P01 · FY2004 · AG
CYTOSKELETAL ADHESION IN CARDIAC REMODELING$194,987
R01 · FY2003 · HL
Akt activation as treatment for dilated cardiomyopathy$176,311
R01 · FY2003 · HL
Akt activation as treatment for dilated cardiomyopathy$119,689
R01 · FY2003 · HL
CYTOSKELETAL ADHESION IN CARDIAC REMODELING$101,013
R01 · FY2003 · HL
Core--Adenovirus$305,975
P01 · FY2002 · HL
Akt activation as treatment for dilated cardiomyopathy$296,000
R01 · FY2002 · HL
CYTOSKELETAL ADHESION IN CARDIAC REMODELING$296,000
R01 · FY2002 · HL
Akt activation as treatment for dilated cardiomyopathy$296,000
R01 · FY2001 · HL
CYTOSKELETAL ADHESION IN CARDIAC REMODELING$296,000
R01 · FY2001 · HL
NEONATAL CARDIAC RESPONSE TO MYOFILAMENT DEGENERATION$103,600
R01 · FY2001 · HL
NEONATAL CARDIAC RESPONSE TO MYOFILAMENT DEGENERATION$103,600
R29 · FY2000 · HL